GlassScriptPhysician profile
Kamal Singh
NPI 1962866756
$25,773.64
in general payments reported to CMS, 2019-2025
30 companies · $5,617 in 2025
The $5,617 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,486 · 2022: $3,799 · 2023: $2,359 · 2024: $11K · 2025: $5,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,828 · Travel and Lodging: $7,346 · Grant: $1,126 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,828.05 |
| Travel and Lodging | $7,346.34 |
| Grant | $1,126.44 |
| Education | $188.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,684.40 | 2021-2025 | Watchman Flx, Versacross Access Solution, Avvigo Guidance System |
| Abiomed | $4,578.25 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $3,718.10 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Biotronik INC. | $2,805.42 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $2,058.55 | 2024-2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Cvrx, INC. | $975.29 | 2021-2025 | Barostim Neo System |
| Aop Health US, LLC | $897.63 | 2025 | Rapiblyk |
| Baylis Medical Company INC | $816.82 | 2021 | |
| Bardy Diagnostics, INC. | $789.57 | 2021 | |
| Abbott Laboratories | $444.31 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $419.46 | 2021-2023 | Xarelto |
| Amgen INC. | $357.69 | 2023-2025 | Repatha, Repatha |
| Philips North America LLC | $328.11 | 2022 | |
| Nuwellis, INC. | $307.86 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.79 | 2024-2025 | Lifevest |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $226.46 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $195.59 | 2023-2025 | |
| Medtronic, INC. | $192.61 | 2021-2022 | |
| Irhythm Technologies, INC. | $175.56 | 2024 | Zio Xt Patch, Zio Monitor |
| Cordis US Corp. | $149.38 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $122.88 | 2023 | Amvuttra |
| Angiodynamics, INC. | $93.78 | 2023 | Angiovac |
| Merck Sharp & Dohme LLC | $39.64 | 2022-2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $33.33 | 2022-2025 | Camzyos |
| Daiichi Sankyo INC. | $28.60 | 2023 | Injectafer |
| Bridgebio Pharma, INC. | $26.02 | 2025 | Attruby |
| Amarin Pharma, INC. | $20.36 | 2021 | |
| Esperion Therapeutics, INC. | $17.12 | 2025 | Nexletol |
| Scpharmaceuticals INC. | $16.92 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $16.14 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamal Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.